CN Patent
CN116234917A — Dna分子组合物及其制备方法和使用方法
Assigned to National Disaster Resilience Limited Liability Company · Expires 2023-06-06 · 3y expired
What this patent protects
本文提供了包含反向重复序列、表达盒和切口核酸内切酶的一个或多个限制性位点的双链DNA分子、其使用方法及其制备方法。
USPTO Abstract
本文提供了包含反向重复序列、表达盒和切口核酸内切酶的一个或多个限制性位点的双链DNA分子、其使用方法及其制备方法。
Drugs covered by this patent
- Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.